EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

VERONA is a phase II trial evaluating the company's lead investigational product Duravyu in diabetic macular edema ... as measured by optical coherence tomography (OCT) and change in diabetic ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

One of the critical applications of OCT is the segmentation of retinal fluids, which can indicate conditions such as diabetic macular edema and age-related macular degeneration. Recent research ...

Three experts discuss the increased mortality risk for patients with diabetic retinopathy, available screening tools, and ...

Opthea's lead compound, sozinibercept, targets VEGF-C/D and is in Phase 3 trials for wet AMD. Read more to see why I'm ...

A 65-year-old female patient with type 2 diabetes mellitus and hypercholesterolemia ... Optical coherence tomography (OCT) of the fovea showed serous macular detachment and nasally cystoid macular ...

Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.

This trial is designed to evaluate 4D-150 in diabetic macular edema (DME ... of +8.4 letters Sustained reduction of CST, as measured by optical coherence tomography (OCT), of -194 µm Supplemental ...

Diabetic Macular Edema,E-learning,Early Detection,Early Disease,Early Identification Of Disease,Early Stopping,Field Of Ophthalmology,Hybrid Model,Image Processing,Image Processing Techniques,Macular ...

The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...